• 1
    Chang WWL. Histogenesis of colon cancer in experimental animals. Scand J Gastroenterol 1984; 19: 2743.
  • 2
    Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987; 37: 14751.
  • 3
    Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA, Stellato TA. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res 1991; 51: 15647.
  • 4
    Roncucci L, Stamp D, Medline A, Cullen JB, Bruce WR. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 1991; 22: 28794.
  • 5
    McLellan EA, Medline A, Bird RP. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res 1991; 51: 52704.
  • 6
    McLellan EA, Medline A, Bird RP. Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon. Carcinogenesis 1991; 12: 20958.
  • 7
    Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C, Salvadori M, Dolara P. Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res 2003; 63: 238892.
  • 8
    Femia AP, Dolara P, Caderni G. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis. Carcinogenesis 2004; 25: 27781.
  • 9
    Pierre F, Freeman A, Taché S, Van der Meer R, Corpet DE. Beef meat and blood sausage promote azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colons. J Nutr 2004; 134: 27116.
  • 10
    Polakis P. The oncogenic activation of β-catenin. Curr Opin Genet Dev 1999; 9: 1521.
  • 11
    Hao XP, Pretlow TG, Rao JS, Pretlow TP. β-catenin expression is altered in human aberrant crypt foci. Cancer Res 2001; 61: 80858.
  • 12
    Herter P, Kuhnen C, Muller KM, Wittinghofer A, Muller O. Intracellular distribution of β-catenin in colorectal adenomas, carcinomas, and Peutz-Jeghers polyps. J Cancer Res Clin Oncol 1999; 125: 297304.
  • 13
    Corpet DE, Taché S. Most effective colon cancer chemopreventive agents in rats: a review of aberrant crypt foci and tumour data, ranked by potency. Nutr Cancer 2002; 43: 121.
  • 14
    Zheng Y, Kramer PM, Lubet RA, Steele VE, Keloff GJ, Pereira MA. Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci. Carcinogenesis 1999; 20: 25560.
  • 15
    Carter JW, Lancaster HK, Hardman WE, Cameron IL. Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumours in the large bowel of 1,2-dimethylhydrazine-treated mice. Cancer Res 1994; 54: 43047.
  • 16
    European Community. European Community regulations on the care and use of laboratory animals: law 86/609/EC. Luxembourg: European Community, 1986.
  • 17
    Caderni G, De Filippo C, Luceri C, Salvadori M, Giannini A, Biggeri A, Remy S, Cheynier V, Dolara P. Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane (AOM) in F344 rats. Carcinogenesis 2000; 21: 19659.
  • 18
    Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, Caderni G. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002; 23: 195360.
  • 19
    Yamada Y, Yoshimi N, Hirose Y, Kawabata K, Matsunaga K, Shimizu M, Hara A, Mori H. Frequent β-catenin gene mutations and accumulation of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res 2000; 60: 33237.
  • 20
    Koesters R, Hans MA, Benner A, Prosst R, Boehm J, Gahlen J, Doeberitz MK. Predominant mutation of codon 41 of the beta-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol. Carcinogenesis 2001; 22: 188590.
  • 21
    Magnusson BA, Carr I, Bird RP. Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res 1993; 53: 4499504.
  • 22
    Shpitz B, Hay K, Medline A, Bruce WR, Bull SB, Gallinger S, Stern H. Natural history of aberrant crypt foci, a surgical approach. Dis Colon Rectum 1996; 39: 7637.
  • 23
    Pitot HC, Dragan YP. Chemical carcinogenesis. In: KlaasenCD, ed. Casarett and Doull's toxicology: the basic science of poisons. New York: McGraw-Hill, 2001. 241320.
  • 24
    Yamada Y, Yoshimi N, Hirose Y, Matsunaga K, Katayama M, Sakata K, Shimizu M, Kuno T, Mori H. Sequential analysis of morphological and biological properties of β-catenin accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res 2001; 61: 33237.
  • 25
    Preston SL, Wong WM, Chan AO, Poulsom R, Jeffery R, Goodlad RA, Mandir N, Elia G, Novelli M, Bodmer WF, Tomlinson IP, Wright NA. Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res 2003; 63: 381925.
  • 26
    Shih IM, Wang TL, Traverso G, Romans K, Hamilton SR, Ben-Sasson S, Kinzler KW, Vogelstein B. Top down morphogenesis of colorectal tumors. Proc Natl Acad Sci USA 2001; 98: 26405.
  • 27
    Tudek B, Bird RP, Bruce WR. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res 1989; 49: 123640.
  • 28
    Maskens AP. Histogenesis and growth pattern of 1,2-dimethylhydrazine-induced rat colon adenocarcinoma. Cancer Res 1976; 36: 158592.
  • 29
    Glauert HP, Week JA. Dose- and time-response of colon carcinogenesis in Fisher-344 rats after a single dose of 1,2-dimethylhydrazine. Toxicol Lett 1989; 48: 2837.
  • 30
    Yoshimi N, Morioka T, Kinjo T, Inamine M, Kaneshiro T, Shimizu T, Suzui M, Yamada Y, Mori H. Histological and immunohistochemical observations of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1,2-dimethylhydrazine dihydrochloride. Cancer Sci 2004; 95: 7927.
  • 31
    Caderni G, Giannini A, Lancioni L, Luceri C, Biggeri A, Dolara P. Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis. Br J Cancer 1995; 71: 7639.
  • 32
    Brabletz T, Herrmann K, Jung A, Faller G, Kirchner T. Expression of nuclear β-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol 2000; 156: 86570.
  • 33
    Hao X, Tomlinson I, Ilyas M, Palazzo JP, Talbot IC. Reciprocity between membranous and nuclear expression of β-catenin in colorectal tumours. Virch Arch 1997; 431: 16772.
  • 34
    Paulsen JE, Steffensen IL, Loberg EM, Husoy T, Namork E, Alexander J. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon. Cancer Res 2001; 61: 50105.
  • 35
    Iwamoto M, Ahnen DJ, Franklin WA, Maltzman TH. Expression of β-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis 2000; 21: 193540.
  • 36
    Sellin JH, Umar S, Xiao J, Morris AP. Increased β-catenin expression and nuclear translocation accompany cellular hyperproliferation in vivo. Cancer Res 2001; 61: 2899906.
  • 37
    Van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002; 111: 24150.
  • 38
    Blum CA, Xu M, Orner GA, Fong AT, Bailey GS, Stoner GD, Horio DT, Dashwood RH. β-catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol. Carcinogenesis 2001; 22: 31520.
  • 39
    Yamada Y, Oyama T, Hirose Y, Hara A, Sugie S, Yoshida K, Yoshimi N, Mori H. β-catenin mutation is selected during malignant transformation in colon carcinogenesis. Carcinogenesis 2003; 24: 917.
  • 40
    Takahashi M, Fukuda K, Sugimura T, Wakabayashi K. β-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res 1998; 58: 426.
  • 41
    Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K. Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis 2000; 21: 131927.